Source: Zolmax News

LogicBio: LogicBio Therapeutics (NASDAQ:LOGC) & Aptose Biosciences (NASDAQ:APTO) Financial Review

LogicBio Therapeutics (NASDAQ:LOGC) and Aptose Biosciences (NASDAQ:APTO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations and valuation. Earnings & Valuation This table compares LogicBio Therapeutics and Aptose Biosciences' gross revenue, earnings per [...]

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Frederic Chereau's photo - President & CEO of LogicBio

President & CEO

Frederic Chereau

CEO Approval Rating

82/100

LogicBio is a biotechnology company that develops genetic medicines to treat rare pediatric diseases. Read more